Preventive effect of celecoxib use against cancer progression and occurrence of oral squamous cell carcinoma

@article{Chiang2017PreventiveEO,
  title={Preventive effect of celecoxib use against cancer progression and occurrence of oral squamous cell carcinoma},
  author={Shang-Lun Chiang and B. Velmurugan and Chia-Min Chung and Shu-Hui Lin and Zhi-hong Wang and Chun-Hung Hua and M. Tsai and T. Kuo and K. Yeh and P. Chang and Yi-Hsin Yang and Y. Ko},
  journal={Scientific Reports},
  year={2017},
  volume={7}
}
Overexpression of cyclooxygenase-2 in oral cancer increases lymph node metastasis and is associated with a poor prognosis. The potential of celecoxib (CXB) use is reported in cancer treatment by inhibiting proliferation through apoptosis, but the effects on the epithelial-mesenchymal transition (EMT) and cancer cell mobility remain unclear. We performed a preclinical study and population-based study to evaluate CXB use in the prevention of oral cancer progression and occurrence. The in-vitro… Expand
Combination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells
Celecoxib suppresses lipopolysaccharide-stimulated oral squamous cell carcinoma proliferation in vitro and in vivo
...
1
2
...

References

SHOWING 1-10 OF 66 REFERENCES
Targeting apoptosis pathways by Celecoxib in cancer.
Celecoxib: a specific COX-2 inhibitor with anticancer properties.
...
1
2
3
4
5
...